Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biolase gets US nod for eye laser:

This article was originally published in Clinica

Executive Summary

Marking an "important milestone in its ophthalmic pursuits", Biolase Technology, a company that makes laser systems for use primarily in dentistry, has gained US clearance to sell its Oculase MD laser system for general ophthalmic soft tissue surgical indications. The approval represents an "early achievement along the path to developing a treatment for presbyopia", said the Irvine, California firm. It also enables Biolase to pursue other applications using its core technology in ophthalmology, and will improve its ability to move forward with its clinical research and sales and marketing initiatives for Oculase MD, both domestically and internationally, said the company. Oculase MD is the first Er,Cr:YSGG laser system cleared for ophthalmic applications, Biolase added.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel